Followers | 32 |
Posts | 3638 |
Boards Moderated | 0 |
Alias Born | 10/04/2010 |
Thursday, July 31, 2014 11:14:30 AM
Wrong
"What CEO tells shareholders every little intricacy of what is going on with the company?"
Where did I mention "every little intricacy" in my quote?...lol. Might I add that I've certainly seen PRs from other companies providing far more detail about their operations, I guess you haven't.
"Kim is under no obligation to tell shareholders a thing, if he chose not to do so."
Wrong again...If you want to be a fully reporting company, you need to tell your shareholders something. Look it up, they're called "filings"
"Folks just need to relax and let Kim run the ship"
They can do whatever they want...it's a public company and Kim chose the route(s) he chose. People have a right to complain if they don't agree with his methods.
"Trust is what matters. I have total faith and trust in Kim and Ben. It is obvious that some folks do not, and therein lies the problem."
No, it's not really a problem unless it's apparent that your agenda isn't going over so well. Then it's YOUR problem.
I always tell the truth, even when I lie
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM